Are compounded vs brand GLP-1 medications reviewed for safety in the same way?

FDA approval and pharmacy licensing are different types of oversight. Before approving a brand medicine, the FDA reviews evidence about its benefits and risks, along with information about manufacturing and quality. Approval does not mean a medicine is risk-free or right for everyone.

Compounded medications are prepared by a licensed pharmacy for one patient and are not FDA-approved. They do not undergo FDA review for safety, effectiveness, or quality before they reach patients. State-licensed pharmacies are generally overseen by state pharmacy boards, and federal rules also apply. That oversight does not turn a compounded prescription into an FDA-approved product.

Compounded medicines can carry risks from contamination, incorrect strength, or dosing errors. Brand medicines also have warnings, side effects, and storage requirements. Neither choice should be treated as harmless because it comes from a pharmacy.

A licensed physician in your state decides whether treatment is appropriate. Before starting, ask about the product’s source, its ingredients, and how to report a problem. Check the label and contact the pharmacy if anything is unclear.